Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewa Robak

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Archives of Medical Science : AMS|May 22, 2019
Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosisEwa Robak, Zofia Gerlicz-Kowalczuk, Bozena Dziankowska-Bartkowiak, et al.
Leukemia Research|April 8, 2021
Cutaneous leukocytoclastic vasculitis at diagnosis of hairy cell leukemia successfully treated with vemurafenib and rituximabEwa Robak, Dorota Jesionek-Kupnicka, Elzbieta Iskierka-Jazdzewska, et al.
Mediators of Inflammation|July 26, 2006
Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosusEwa Robak, Agnieszka Wierzbowska, Magdalena Chmiela, et al.
European Cytokine Network|November 16, 2004
Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosusEwa Robak, Piotr Smolewski, Anna Wozniacka, et al.
Annals of Hematology|February 21, 2022
Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximabEwa Robak, Dorota Jesionek-Kupnicka, Piotr Stelmach, et al.
Przeglad Lekarski|March 18, 2006
[Proinflammatory cytokines in inactive lupus erythematosus patients]Aleksandra Lesiak, Anna Sysa-Jedrzejowska, Joanna Narbutt, et al.
European Cytokine Network|September 17, 2002
Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosusEwa Robak, Tadeusz Robak, Anna Wozniacka, et al.
Leukemia & Lymphoma|December 17, 2002
Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamideTadeusz Robak, Radzisław Kordek, Ewa Robak, et al.
Mediators of Inflammation|April 3, 2014
Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosusAgnieszka Klonowska-Szymczyk, Anna Wolska, Tadeusz Robak, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|October 18, 2017
The impact of agonists and antagonists of TLR3 and TLR9 on concentrations of IL-6, IL10 and sIL-2R in culture supernatants of peripheral blood mononuclear cells derived from patients with systemic lupus erythematosusAgnieszka Klonowska-Szymczyk, Liliana Kulczycka-Siennicka, Tadeusz Robak, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Archives of Medical Science : AMS|May 22, 2019
Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosisEwa Robak, Zofia Gerlicz-Kowalczuk, Bozena Dziankowska-Bartkowiak, et al.
Leukemia Research|April 8, 2021
Cutaneous leukocytoclastic vasculitis at diagnosis of hairy cell leukemia successfully treated with vemurafenib and rituximabEwa Robak, Dorota Jesionek-Kupnicka, Elzbieta Iskierka-Jazdzewska, et al.
Mediators of Inflammation|July 26, 2006
Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosusEwa Robak, Agnieszka Wierzbowska, Magdalena Chmiela, et al.
European Cytokine Network|November 16, 2004
Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosusEwa Robak, Piotr Smolewski, Anna Wozniacka, et al.
Annals of Hematology|February 21, 2022
Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximabEwa Robak, Dorota Jesionek-Kupnicka, Piotr Stelmach, et al.
Przeglad Lekarski|March 18, 2006
[Proinflammatory cytokines in inactive lupus erythematosus patients]Aleksandra Lesiak, Anna Sysa-Jedrzejowska, Joanna Narbutt, et al.
European Cytokine Network|September 17, 2002
Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosusEwa Robak, Tadeusz Robak, Anna Wozniacka, et al.
Leukemia & Lymphoma|December 17, 2002
Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophosphamideTadeusz Robak, Radzisław Kordek, Ewa Robak, et al.
Mediators of Inflammation|April 3, 2014
Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosusAgnieszka Klonowska-Szymczyk, Anna Wolska, Tadeusz Robak, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|October 18, 2017
The impact of agonists and antagonists of TLR3 and TLR9 on concentrations of IL-6, IL10 and sIL-2R in culture supernatants of peripheral blood mononuclear cells derived from patients with systemic lupus erythematosusAgnieszka Klonowska-Szymczyk, Liliana Kulczycka-Siennicka, Tadeusz Robak, et al.
Pageof 8